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Harris and his coworkers  showed that DNA and RNA synthesis could be activated 
in the nuclei of dormant cells  after virus-mediated fusion with cells which actively 
make  these  nucleic acids  (1).  Subsequent studies  documented the  importance  of 
nuclear swelling during the activation process,  especially in relation to the increase 
in RNA synthesis (2). 
When mouse peritoneal macrophages were  fused with  a  mouse melanocyte cell 
line, the macrophage nuclei were also  activated (3).  These nuclei became enlarged, 
their RNA synthesis was stimulated, and DNA synthesis was initiated. In addition 
to  these  changes  the  activation of  macrophage  nuclei in macrophage-melanocyte 
heterokaryons presents a  feature of  special interest.  Unfused macrophages  do  not 
divide in vitro because of a  block which precedes  DNA synthesis, in the Go period 
of the cell cycle (4, 5). It is widely held that the reentry of Go cells into S represents 
a  key step  in the control of  DNA synthesis and subsequent mitosis in eukaryofic 
cells  (6). We have therefore studied the initiation of macrophage DNA synthesis in 
heterokaryons to learn more about the Go state and its reversal. 
In the present paper we  describe the kinetics of  activation of macrophage 
DNA synthesis in heterokaryons. The role of  RNA synthesis in this process 
was  examined using inhibitors and experiments were  designed to  distinguish 
the contributions of each parental cell to the heterokaryon. 
Materials and Methods 
Cell cultivation  and the method of virus-induced cell fusion have been described previously 
(3). 2 X  l0  G  macrophages were cultivated  on 12 mm cover glasses for 1 day. 1-day old cul- 
tures of exponentially growing melanocytes were used for all the experiments reported in this 
paper. Freshly trypsinized melanocytes were seeded onto the macrophage monolayer for 1 hr 
before adding 500 hemagglutinating units of ultra-violet irradiated Sendai virus. After 30 rain 
treatment with virus at 37°C, the preparations were washed and cultivated further in medium 
199 -]- 10% newborn calf serum (199 M).I 
* This work was partially supported  by Grant AI-02012-05 and S1  from the  National 
Institutes of Health, Bethesda, Md. 
1  The following abbreviations  are  used in this paper:  MEM,  Eagle's  minimal essential 
medium; 1  : 1 heterokaryons, a heterokaryon containing one macrophage and one melanocyte 
nucleus; 199 M, Medium 199 -}- 10% newborn calf serum. 
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DNA and RNA synthesis were studied in fused preparations by radioautography. Cells 
were incubated in 199 M containing aH-thymidine, 10/~Ci/ml for 2 hr or longer, or 3H-uridine, 
10/zCi/ml for 20 or 60 rain. These preparations were processed as described previously (3). At 
least 25  1:1  heterokaryons (heterokaryons containing one macrophage and one melanocyte 
nucleus)  were evaluated per cover glass, usually in duplicate preparations. DNA synthesis 
was scored +  or -  for each nucleus based on heavy labeling over background. RNA synthesis 
was evaluated by counting grains. Unfused macrophages and melanocytes served as controls 
in each preparation. 
Chick red cel/-melanocyte heterokaryons were prepared as follows:  The red cells of 11  or 
12-day  old chick embryos were washed twice in 199 M, resuspended in 199 M, and pipetted 
onto glass cover slips (1  X  10~/cm2). After 1 hr at room temperature, 1 X  104 exponentially 
growing melanocytes, suspended in 199 M, were added to each cover slip. After another hour of 
incubation at 37°C  the cells were treated with 500  hemagglutinating units of  inactivated 
Sendal virus for 30 rain,  washed twice, and cultivated in  199M.  DNA  synthesis of hetero- 
karyons was  measured  by  radioautography,  using four consecutive 2  hr  pulses with  3H- 
thymidine 1 hr after treatment with virus, and another pulse 18-20 hr after fusion. 
The inhibitors used in the present experiments, actinomycin D and bromotubercidin, were 
obtained from Dr. E. Reich of The Rockefeller University. Concentrated stock solutions were 
stored at --20°C and thawed and diluted immediately before use. 
The effect of these drugs on DNA, RNA and protein synthesis in unfused cells was studied 
by measuring the incorporation of tritiated precursors into trichloroacetic acid (TCA)-insoluble 
products. L-leucine-4,  53H, 44 Ci/mM,  uridine-5-3H,  25.9 Ci/mM, and thymidine-methyl-3H, 
2.0 Ci/mM, were all purchased from the New England Nuclear Corp., Bedford, Mass. and 
used at 5/zCi/ml in Eagle's minimal essential medium (MEM) with 10%  calf serum. Repli- 
cate cultures were prepared for these incorporation studies by cultivating 1.2  X  10 a melano- 
cytes or 3  X  l0  s macrophages in 35 mm tissue culture dishes (Falcon Plastics, LGs Angeles, 
Calif.)  for 1 day in MEM +  10% calf serum. The cells were washed and treated with each 
drug in the presence of the appropriate precursor. After drug treatments of varying duration 
the cells were washed 3 times with MEM and incubated further in the presence of radioactive 
tracer. At various times the incorporation  into TCA-insoluble products was  measured  as 
follows. The cells were washed 2 times with ice-cold saline, scraped in saline, and prec[pit~ ted 
with an equal volume of 10% TCA. The precipitates were washed 2 times in 2.5% TCA and 
dissolved in 2V-NaOH. Samples were counted in Bray's solution ina Mark II liquid scintillation 
counter with an efficiency of 34%. The results were expressed as cpm/#g protein. The protein 
content of samples was determined by the Lowry method (7). 
Inhibitors were also used in cell fusion experiments, either preceding or following treatment 
with virus. In pretreatment experiments one cell partner was treated with a particular drug, 
washed 3 times, and fused with untreated cells 1 hr later. Controls for these experiments al- 
ways included pretreatment of the other parent, as well as cells fused without drug treatment. 
In posttreatment experiments, the inhibitor was added to cocultivated cells either at the same 
time as the virus or afterwards. After treatment with the drug the fused cells were washed 3 
times and cultivated further in 199M. 
RESULTS 
The  morphological  changes  which  take  place  in  macrophage-melanocyte 
heterokaryons have been  described  previously (3). The macrophage  nucleus 
becomes  larger,  contains  more  prominent nucleoli,  and  exhibits  stimulated 
RNA and new DNA synthesis.  The kinetics  of activating macrophage  DNA 
synthesis in heterokaryons were next determined. SAIMON  GORDON  AND  ZANVIL  COttN  323 
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FIG.  1.  DNA synthesis in 1:1 heterokaryons at different times after fusion, a, b,  macro- 
phage-melanocyte  heterokaryons  (X ...... X  melanocyte  labeling,  X  X  macrophage 
labeling); c, erythrocyte-melanocyte heterokaryons. 
TABLE  I 
The Pattern of Labeling in Multiple Heterokaryons  after a 3H-Thymidine Pulse 
9-12 Hr After Fusion 
Cell 
composition* 
Total No, of  Labeling pattern*  Per cent of all 
No. of cells  melanocytes 
cells scored  Macrophage  Melanocyte  labeled 
0:1 
l:l 
2:1 
3:1 
4:1 
100  +  66  66 
--  34 
60  +  +  30  57 
--  +  4 
+  --  7 
--  --  19 
30  ++  +  14  57 
+-  +  2 
+  1 
++  -  5 
----  --  8 
30  +++  +  16  60 
++-  +  2 
+  --  --  1 
++-  --  1 
+++  -  3 
-  7 
25  ++++  +  12  48 
++++  --  1 
-  12 
* The number of macrophage nuclei is listed first, i.e., a  3:1  cell has three macrophage 
nuclei and one melanocyte nucleus. 
:~ The macrophage nuclei are enumerated first, the melanocyte nucleus last. For example, 
+  +  -- +, a 3 : 1 heterokaryon with two macrophage and one melanocyte nucleus labeled. 324  MACROPHAGE--MELANOCYTE  HETEROKARYONS.  II 
DNA  Synthesis in  Macrophage-Metanocyte Heterokaryons.--Newly  formed 
heterokaryons were  exposed  to  consecutive 2  hr  pulses  with  3H-thymidine. 
DNA synthesis, at different times after fusion, is illustrated in Figs. 1 and 2. As 
can be seen in Fig. 1 a, the number of melanocyte nuclei which were labeled in 
heterokaryons remained constant throughout the  11 hr period after the start 
of fusion.  The macrophage  nuclei  in  heterokaryons,  however,  did  not  start 
DNA synthesis until 3 hr after fusion. Over the following 4 hr period macro- 
phage nuclei became labeled in most heterokaryons containing a labeled melano- 
cyte nucleus. After 9 hr about 10% of macrophage nuclei were labeled in the 
absence of melanocyte labeling.  Melanocyte DNA synthesis in  these hetero- 
karyons was probably complete by this time. 
The kinetics of macrophage DNA synthesis initiation proved to be remark- 
ably constant. An irreducible delay of 2-3 hr and the steep rise of the activation 
curve were  characteristic  features.  Since  50-80%  of  macrophage  nuclei  in- 
variably started  DNA  synthesis within  3-8  hr  of fusion,  it  was  possible  to 
assay this parameter of macrophage nuclear activation reliably. The ratio of 
macrophage-  to melanocyte-labeled nuclei  also provided a  good indicator of 
the degree of activation,  as illustrated in Fig.  1 b. 
The  activation  of  DNA  synthesis  is  specific for  heterokaryons.  Unfused 
macrophages  or  macrophage  homokaryons  were  never  found  labeled,  thus 
excluding  a  nonspecific  effect of  cell fusion  itself.  Since  the  macrophage  is 
capable of RNA and protein synthesis it was thought possible that the macro- 
phage  could  actively  inhibit  melanocyte  DNA  synthesis  in  heterokaryons. 
This is, however, not the case, as shown in Table I. The frequency of melanocyte 
DNA synthesis was  unaffected in heterokaryons containing as many as four 
macrophage  nuclei.  Moreover,  the  nuclei  of  multiple  heterokaryons  often 
labeled in synchrony, as illustrated also in Fig. 2 b. 
As  reported previously, more than  80%  of  1:1  heterokaryons could enter 
mitosis  within  24-48  hr  of  fusion  (3).  Further  proliferation,  however,  was 
sluggish compared with that in unfused melanocytes. 
DATA Synthesis in Chick Erythrocyte-Melanocyte Heterokaryons.--The above 
studies suggested that macrophage nuclei were induced to make DNA sooner 
than were chick erythrocyte nuclei placed in HeLa cytoplasm (8). DNA synthe- 
sis  in macrophage and erythrocyte nuclei was  therefore compared in  similar 
cytoplasm by fusing both types of cell with melanocytes. The pooled results of 
three erythrocyte-melanocyte fusion experiments are shown in Fig.  1 c. The 
crosses represent the mean of three observations; the bars represent their range. 
DNA synthesis in the chick nuclei started after a lag which varied from 5 hr 
after fusion for a few nuclei,  to more than 9 hr after fusion for most of the 
nuclei. This heterogeneity was present among different cells within the same 
experiment, as well as in different experiments. By 20 hr 48-70%  of red cell SAIMON  GORDON  AND  ZANVIL  COHN  325 
nuclei were labeled. In parallel experiments macrophage DNA synthesis had 
started by 3 hr and was found in 70 % of 1 : 1 heterokaryons by 7 hr. 60-70 % of 
melanocyte  nuclei  were  labeled  in  both  types  of  heterokaryon  throughout 
these experiments. 
The macrophage nucleus  therefore differs from the  erythrocyte nucleus  in 
the relative speed and homogeneity with which DNA synthesis is activated in 
heterokaryons. 
RNA  Synthesis  in  Heterokaryons.--Heterokaryon  formation  results  in  an 
increase in macrophage RNA synthesis, as reported previously (3). The kinetics 
of this process are shown in Table II. Stimulated  RNA synthesis can be de- 
tected within an hour of fusion and shows a 2-fold increase by 2 hr  (Fig. 2 c). 
TABLE  II 
The Incorporation of Uridine into Macrophage Nuclei* 
Binucleate homokaryons  Ratio of hetero- 
Hr after fusion  Unfused cells  1:1 Heterokaryons  (per nucleus)  karyons to 
unfused cells 
Mean SD  Mean SD  Mean  SD 
1  22.2  4-  5.9  33.7  4- 9.8  29.5  4-4-9.0  1.5 
2  18.2  4-4- 4.8  33.8  4-4- 8.6  25.8  4-7.5  1.9 
3  19.8  4-  5.8  43.7  4-4- 10.5  26.1  4--4-10.4  2.2 
41~  19.2  4-  5.7  43.4  4-  7.7  24.6  4-5.6  2.3 
51~  27.4  4-  5.7  55.5  4-  16.8  32.1  4-9.8  2.0 
No. of grains per macrophage nucleus. 
* No. of cells, 25; pulse, 20 min. 
There is little further increase in macrophage RNA synthesis in heterokaryons 
relative to that in unfused macrophages. A lesser stimulation of RNA synthesis 
takes place in macrophage homokaryons. 
After labeling with uridine  for 20 rain,  grains were found  over nucleoli  as 
well as scattered over the rest of the nucleus (Fig. 2 c). Fewer than 10% of the 
total grains were present over the cytoplasm of cells. After longer periods of 
labeling, or after a 40 rain "chase" with nonradioactive uridine,  there was an 
increase in cytoplasmic label of both fused and unfused cells. It was not possible 
to  establish  by  means  of  grain  counts,  however,  whether  the  macrophage 
nuclei  contributed  I~NA to the heterokaryon cytoplasm. 
Macrophage  nuclei,  therefore,  make  RNA  at  the  time  of fusion  and  the 
further stimulation in RNA synthesis in the heterokaryons precedes their DNA 
synthesis.  Further  experiments were undertaken  to determine  if macrophage 
DNA synthesis depended  on heterokaryon RNA synthesis,  and in particular, 
macrophage RNA synthesis. Two compounds, acfinomycin D  and bromotuber- 
cidin,  were used  to inhibit  RNA  synthesis. 326 SAI~ON GORDON AND  ZANVIL COHN  327 
The Effect of Actinomycin  on RNA, DNA,  and Protein Synthesis.--Actino- 
mycin depressed RNA synthesis irreversibly in both melanocytes and macro- 
phages after treatment for  1 hr  (Table III). 85-99 %  inhibition of RNA syn- 
thesis  could be  obtained, in both  cells,  in the  dose  range  1-5  #g/ml. When 
macrophages were  exposed  to  actinomycin and aH-uridine at the  same  time, 
the  inhibition of  uridine incorporation occurred somewhat more slowly than 
in melanocytes, but after a few hours macrophage RNA synthesis was affected 
more  extensively. Many macrophages  were  dead  5  hr  after  treatment with 
5 #g/ml. 
Protein synthesis in both cell types was inhibited to a lesser extent than RNA 
synthesis, especially in the first hours of exposure and only one-third of protein 
synthesis was inhibited over the 6 hr period which followed treatment with 5 
/zg/ml. Melanocyte DNA synthesis was unaffected for the first hour, but up to 
two-thirds inhibition followed treatment with 5 #g/ml. 
Macrophage DNA  Synthesis  in tteterokaryons  Treated with  Actinomycin.-- 
The results of an experiment in which heterokaryons were treated with actino- 
mycin, 1/~-1  1/~  hr  after  fusion,  are  illustrated in Fig.  3.  Macrophage  DNA 
synthesis, measured by radioautography, was  prevented by 5  #g/ml  and in- 
FI6. 2 a,  DNA synthesis by both nuclei of a 1:1 heterokaryon. Thymidine pulse 5-7 hr 
after fusion. Stained radioautograph. X 1000. 
FIG. 2 b.  Synchronous DNA synthesis by three macrophage and two melanocyte nuclei 
in a heterokaryon. Thymidine pulse 5-7 hr after fusion. Note the absence of grains over the 
unfused macrophage nucleus. Stained radioautograph.  X  1000. 
FIG. 2 c.  RNA synthesis in a 1  : 1 heterokaryon 2 hr after fusion. The macrophage nucleus 
(arrow) inside the heterokaryon  has more grains and is larger than the adjacent unfused 
macrophage. Uridine pulse 20 re_in. Stained radioautograph. X 1000. 
FIG. 2 d.  RNA synthesis in a  1:1 heterokaryon 2 hr after fusion. The macrophage was 
treated with 1/zg/ml of actinomycin for 1  hr before  fusion. The macrophage nucleus is enlarged 
and is heavily labeled. Uridine pulse 20'. Stained radioautograph.  X  1400. 
FIG. 2 e.  RNA synthesis in a  1:1 heterokaryon  2 hr after fusion. The melanocyte was 
treated with 5/zg/ml actinomycin for 1 hr before fusion. The melanocyte nucleoli are small and 
round. Neither  the melanocyte nor the macrophage nucleus is labeled, whereas an unfused 
macrophage nearby is heavily labeled. Uridine pulse 60'. Stained radioautograph. X 1400. 
FI6. 2 f.  RNA synthesis in a  1  : 1 heterokaryon  2 hr after fusion. The macrophage was 
treated with 5/zg/ml of actinomycin for 1 hr before fusion. The macrophage nucleus is vir- 
tually unlabeled. The melanocyte nucleus shows reduced but definite labeling and the nucleoli 
are smaller than usual, due to actinomycin cross-toxicity. Uridine pulse 60'. Stained radio- 
autograph.  X  1200. 
FIG. 2 g.  Melanocyte after 1 hr of treatment with 5/~g/ml of bromotubercidin. The nucleoli 
appear as numerous, discrete, small bodies. Fixed in 1.25% glutaraldehyde. Phase contrast. 
X  1500. 
Fio. 2 h.  Melanocyte 3 hr after washout, after a 4 hr treatment with 5/~g/ml of bromo- 
tubercidin. The nucleolar masses are larger than during treatment. Fixed in 1.25% glutaralde- 
hyde. Phase contrast. X  1500. TABLE III 
The Effect of A ctinomycin  on RNA, Protein, and DNA Synthesis in  UnJused Cells* 
Dose 
Tracer  Actino-  Time 
mycin 
Incorporation  (cpm/~g protein)  Per cent Inhibition 
Melanocyte  Macrophage  Melanocyte  Macro-  phage 
3H-Uridine 
~ml  (hr) 
0  1  150  150 
3  508  462 
6  948  908 
aH-Leucine 
3H-Thymidine 
0.1  1  74 
3  200 
6  422 
1.0  1  16 
3  63 
6  145 
5.0  1  7 
3  7 
6  25 
0  1  32 
3  97 
6  188 
0.1  1  N.D. 
3  N.D. 
6  N.D. 
1.0  1  32 
3  84 
6  171 
5.0  1  34 
3  64 
6  118 
0  1  82 
4  334 
7  550 
0.1  1  94 
4  370 
7  680 
1.0  1  84 
4  204 
7  326 
5.0  1  72 
4  124 
7  184 
90 
171 
235 
30 
50 
41 
21 
17 
17 
11 
31 
52 
I1 
32 
42 
10 
24 
39 
10 
22 
33 
51 
60 
51 
89 
88 
85 
95 
99 
97 
N.D. 
N.D. 
N.D. 
0 
13 
9 
0 
34 
37 
0 
0 
0 
0 
39 
41 
12 
63 
67 
40 
63 
74 
80 
89 
96 
85 
97 
98 
0 
0 
19 
8 
22 
25 
8 
28 
36 
* Cells were  treated with acfinomycin for  1 hr in the presence of radioactive precursor, 
washed 3 times, and incubated further in fresh precursor. 
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hibited,  to  a  lesser extent,  by 0.5 #g/rot. A  dose of 0.05  #g/ml had no effect. 
The number of labeled melanocyte nuclei did not fall appreciably,  even after 
5  #g/ml,  but  the  intensity  of their  labeling  did  diminish  towards  the  end  of 
the experiment. 
Several  morphologic  changes  were  observed  in  preparations  treated  with 
actinomycin. The melanocyte nucleoli were characteristically small and round 
(see Fig.  2 f).  There was considerable  macrophage cell death  after  treatment 
with 5/~g/ml,  but heterokaryons survived, like the unfused melanocytes. The 
swelling  of the  macrophage nuclei  in  these  heterokaryons  was  unaffected by 
actinomycin treatment. 
The  initiation  of  macrophage  DNA  synthesis  was  therefore  sensitive  to 
actinomycin  treatment  started  1/~  hr  after  fusion.  The  relationship  between 
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FIG. 3. The effect of actinomycin treatment on the initiation of macrophage DNA synthe- 
sis in 1 : 1 heterokaryons. Per cent of labeled melanoeyte nuclei in brackets• 
the timing of cell fusion and the period of actinomycin sensitivity was examined 
by  treating  cocultivated  cells  with  actinomycin  at  different  times  before  or 
after fusion. 
Freshly  trypsinized  melanocytes were seeded on macrophage  monolayers and  the cells 
cocultivated for 3 hr before fusion. At hourly intervals, starting  2 hr before fusion and ending 
5 hr after fusion, groups of cover slips were treated with 5 ~t:g/ml actinomycin. After an hour's 
treatment  the preparations  were washed  3  times and cultivated  further.  All groups were 
exposed to 3H-thymidine for two periods, 5-7  and 7-21 hr after  fusion, and processed for 
radioautography.  The results of this experiment are shown in Fig. 4. 
Macrophage  DNA  synthesis  was  most  severely  depressed  when  the  cells 
were  treated  with  actinomycin  2  hr  before  fusion,  but  the  effect  was  still 
striking  when  actinomycin and viral treatment  coincided.  Macrophage DNA 
synthesis was affected to a lesser degree when drug treatment was delayed till 
1-3 hr after fusion, but by the 4th hr treatment was without effect. 50-60% 
of melanocyte nuclei were labeled in all groups. Cell fusion itself was unaffected 
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Low doses of actinomycin D  have been reported to inhibit mainly ribosomal 
RNA  synthesis  (9).  The  selective effects of smaller doses  of actinomycin on 
macrophage DNA synthesis and on melanocyte RNA synthesis were therefore 
compared. This comparison rests on the assumption, to be substantiated later, 
that  the  melanocyte provides  all  the  RNA  necessary for macrophage DNA 
synthesis  to  be  achieved. 
Macrophage DNA synthesis was measured by radioautography, after treating cocultivated 
cells with actinomycin for 1 hr before fusion and exposing the preparations to 3H-thymidine 
1-7 hr after fusion. RNA synthesis was measured in unfused melanoeytes by treating cells for 
1 hr,  washing them,  and  measuring the  incorporation of  3H-uridine into  TCA-insoluble 
product over a 4 hr period. The melanocyte nucleoli provided a sensitive morphologic  indicator 
of actinomycin action in both types of preparation. 
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FIO. 4.  Macrophage DNA synthesis in 1:1 heterokaryons after 5 #g/ml of actinomycin 
treatment  before or after fusion. 
As can be seen in Fig. 5, macrophage DNA synthesis in heterokaryons was 
unaffected by less than 0.1  #g of actinomycin per ml, a  dose which inhibited 
56 % of melanocyte RNA synthesis and which brought about the characteristic 
nucleolar changes. At a higher dose, both macrophage DNA and RNA synthesis 
were  progressively  inhibited.  The  number  of  labeled  melanocyte  nuclei  in 
heterokaryons varied between 63 and 83 % and was undiminished by treatment. 
This  experiment  showed  that  macrophage  DNA  synthesis  could  proceed 
independently  of  a  large  proportion  of  total  RNA  synthesis,  presumably 
mainly ribosomal RNA, but depended on a species of RNA inhibited by >0.1 
#g/ml actinomycin. 
Selective Inhibition of RNA Synthesis before Fusion.--To answer the question 
whether  one or both nuclei  of a  heterokaryon contribute  RNA necessary for 
macrophage DNA synthesis,  each cell was treated with  an inhibitor of RNA 
synthesis  before fusion  with  its  untreated  partner.  The  diffusion  of drug  in 
such experiments from the treated nucleus of a heterokaryon to the untreated SAIMON  GORDON AND  ZANVIL  COHN  331 
nucleus will be referred to as cross-toxicity. The extent to which this occurred 
in pretreatment  experiments was  evaluated from nucleolar morphology and 
by radioautography. 
(a)  Actinomycin  treatment  before cell fusion:  Melanocytes or  macrophages 
were treated with actinomycin, 1, 5,  or 10 #g/ml, for 1 hr before fusion. The 
actinomycin pretreatment  experiments made  it  possible  to  dissociate DNA 
and RNA synthesis in the macrophage nucleus of heterokaryons. After macro- 
phage pretreatment (5 /zg/ml) RNA synthesis was reduced, before and after 
fusion,  while  DNA  synthesis  was  unaffected  (Fig.  6).  Macrophage  RNA 
synthesis amounted to less than 20 % of that found in untreated heterokaryons 
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FIG.  5.  The effect of  different doses of  actinomycin on  (a)  RNA  synthesis in unfused 
melanocytes and (b) the activation of macrophage DNA synthesis in 1:1 heterokaryons. 
during the  1st 4  hr  after fusion.  Cross-toxicity depressed melanocyte RNA 
synthesis in these heterokaryons only moderately (50-70%  of control grain 
counts),  as illustrated in Fig. 2 f. These experiments suggested that macro- 
phage RNA synthesis was not important for its own DNA synthesis. 
When melanocytes were pretreated (1 #g/ml)  the macrophage nuclei made 
no DNA  after fusion. Severe cross-toxicity abolished macrophage as well as 
melanocyte RNA synthesis (Fig. 2 e), however, so that melanocyte pretreat- 
ment did not achieve a selective effect on the melanocyte nucleus. 
Cross-toxicity from the pretreated macrophage nucleus to the melanocyte 
nucleus  of  a  heterokaryon  became  more  severe  (20-30%  of  control  grain 
counts)  after pretreating macrophages with  10  /~g/ml actinomycin and was 
then associated with some depression of macrophage DNA  synthesis. When 
macrophages  were  pretreated  with  1  /~g/ml  actinomycin  the  macrophages 
made  no  RNA  before fusion,  but  were  stimulated after fusion to  make  as 332  MACROPHAGE--MELANOCYTE  ~ETEROKARYONS.  II 
much RNA  as  in untreated heterokaryons (Fig.  2 d)  showing that the sus- 
ceptibility of the macrophage nucleus to actinomycin had changed after fusion. 
(b)  Bromotubercidin  treatment  of cells: Bromotubercidin was used to distin- 
guish between melanocyte and heterokaryon RNA synthesis. This compound 
is  an  adenosine  analogue  which  is  incorporated  into  RNA  and  reversibly 
depresses  RNA synthesis3 It was  therefore likely that melanocyte pretreat- 
ment with bromotubercidin would not subsequently affect macrophage RNA 
synthesis in heterokaryons. 
(1) The effects of bromotubercidin on unfused cells: Bromotubercidin depressed 
84%  of  melanocyte RNA  synthesis  (Table  IV).  RNA  synthesis recovered 
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rapidly after 1 hr of treatment and somewhat more gradually after 5 or 9 hr 
of  treatment.  After a  6  hr period  of  treatment melanocyte RNA  synthesis 
recovered rapidly over the next 8 hr from 19  to 56%  of control total RNA 
synthesis. Protein and DNA  synthesis were  relatively unaffected early, but 
declined later from 68 to 55 %,  and from 75  to 54%  of control, respectively. 
Bromotubercidin treatment caused a  characteristic fragmentation of melano- 
cyte nucleoli which was fully reversible (Fig. 2 g, h). 
After 4 hr of treatment macrophages became rounded up, making 12 %  of 
the  control  RNA.  When  bromotubercidin  was  removed  the  macrophages 
became well spread again and RNA synthesis proceeded at the same rate as 
in  untreated  cells.  Protein synthesis was  little  affected by these  conditions 
(68-75 %  of control). 
These experiments showed that bromotubercidin could suppress RNA syn- 
2 Reich, E., and B. Brdar. Personal communication. TABLE  IV 
The Effect of Bromotubercidin  Treatment  (5 #g/ml) on Biosynthesis  in Unfused Cells 
(a) The rate of RNA synthesis  in melanocytes treated with bromotubercidin for various times, 
based on three determinations at hourly intervals 
Treatment  Rate of incorporation of 3H-urldine  Per cent control 
(cpm/l~g  protein/hr) 
Nil  133 
During treatment  22  16 
(1, 5, or 9 hr) 
After treatment for 
1 hr  180  132 
5 hr  110  83 
9 hr  100  75 
(b)  Melanocyte  RNA, DNA and protein synthesis after 6 hr of treatment and further 
cultivation in the absence of bromotubercidin 
Incorporation 
Hr after  (cpm]~g protein)  Tracer  starting  Per cent control 
treatment  Control  Treated 
3H-Uridine  6  795  54  19 
8  1000  395  39 
10  1295  604  47 
12  1521  1000  56 
3H-Thymidine  6  475  355  75 
8  646  490  75 
10  808  500  62 
12  1008  521  51 
14  1132  630  54 
3H-Leucine  6  220  150  68 
8  295  174  59 
10  362  205  57 
12  440  238  55 
(c)  Macrophage RNA and protein synthesis after 4  hr of treatment and further cultivation 
in the absence of bromotubercidin 
Incorporation 
Hr after  (cpm/pg protein)  Tracer  Starting  Per cent control 
treatment  Control  Treated 
3H-Uridine  4  731  86  12 
5  868  334  39 
6  1051  500  48 
3H-Leucine  4  25  117  68 
5  32  21  66 
6  37  28  75 
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thesis reversibly in melanocytes and macrophages for several hours,  without 
extensive depression of protein or DNA synthesis. 
(2) Bromotubercidin  treatment before cell fusion: Melanocytes or macrophages 
were treated with 5 ~g/ml bromotubercidin for l,  3,  5,  or 7 hr, washed well, 
and fused 1 hr later. Macrophage DNA synthesis in heterokaryons after a 7 hr 
pretreatment of either melanocytes or macrophages is shown in Fig.  7. After 
melanocyte pretreatment  the  initiation  of  macrophage  DNA  synthesis  was 
delayed until 10 hr after fusion. 40-65 % of the melanocyte nuclei were labeled 
throughout  this  experiment,  though  often  less  heavily  than  in  untreated 
controls. 
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RNA  synthesis  was  evaluated  by  radioautography  1-2  hr  after  fusion. 
Treated melanocytes had 30-50%  as many grains  as untreated melanocytes, 
indicating that melanocyte RNA  synthesis had not yet fully recovered. The 
macrophage nuclei of heterokaryons derived from pretreated melanocytes had 
81% as many grains as those in untreated controls (13.7  4- 4.9 compared with 
16.8  -4-  9.0).  Cross-toxicity had therefore not  occurred in these cells.  Shorter 
pretreatment of melanocytes, for 5 or 3 hr,  caused  a similar delay in macro- 
phage DNA synthesis, but the effect was reversed more rapidly. After 1 hr of 
pretreatment no effect on macrophage DNA synthesis  could be detected. 
These experiments indicated that  inhibition of melanocyte RNA  synthesis 
with bromotubercidin reversibly blocked macrophage DNA synthesis without 
affecting macrophage  RNA  synthesis.  Melanocyte RNA  synthesis  by  itself 
was therefore essential for macrophage DNA synthesis and macrophage RNA 
synthesis could not substitute for the melanocyte in  this respect. SALMON  GORDON  AND  ZANVIL  COHN  335 
After  macrophage  pretreatment,  heterokaryon DNA  synthesis  was  indis- 
tinguishable  from  the  control  (Fig.  7).  The  treated  macrophage  nuclei  in 
heterokaryons had 61%  as many RNA grains  as those in untreated controls 
(11.0 ~  5.6 compared with 16.8 :t:  9.0). Melanocyte nuclear grains and mor- 
phology showed that no cross-toxicity had occurred from the treated macro- 
phage nucleus. 
These findings are also compatible with the previous conclusion that macro- 
phage RNA synthesis is not required for DNA synthesis. 
DISCUSSION 
Mouse peritoneal macrophages do not make DNA under the present condi- 
tions of in vitro cultivation. (10) These ceils can, however, be induced to make 
DNA in vitro when treated with conditioned medium derived from L-cells, or 
when infected with polyoma virus (11,  12). In the present studies DNA syn- 
thesis was  stimulated  in dormant macrophage nuclei by fusion with rapidly 
proliferating  melanoma  ceils.  This  stimulation  occurred  even  when  several 
macrophages were fused with a  single melanocyte and often resulted in syn- 
chronous DNA synthesis in all the nuclei, a  common finding in other multi- 
nucleated ceils (1, 6,  13,  14). The nondividing mouse peritoneal macrophage, 
therefore, seems be be lacking in elements which induce DNA synthesis rather 
than actively inhibiting this process (15). 
Macrophage  DNA  synthesis  lags  2-3  hr  behind  that  of  the  melanocyte 
nucleus  in  the  same  cytoplasm and  the  chick erythrocyte nucleus  responds 
even more slowly, whether in melanocyte or HeLa cytoplasm (8). The delay 
in the onset of macrophage DNA synthesis is not an artifact due to prolonged 
fusion, which is often completed in 1/6 hr. Moreover, HeLa nuclei in G1 have 
been reported to start DNA synthesis within an hour of fusion with other HeLa 
cells which are already in S (16). 
The heterochromatin content of macrophage and erythrocyte nuclei could 
account for the different kinetics of initiating DNA synthesis in heterokaryons. 
DNA  replication  in  heterochromatin  can  occur  later  than  in  euchromatin, 
even when present in the same  nucleus  (6). Bolund and his  coworkers have 
shown  that  reactivation of the  chick red  cell nucleus in  HeLa cytoplasm is 
associated  with  marked  changes  in  its  chromatin  structure,  revealed  by 
changes in thermal stability and the binding of acridine orange (8). Perhaps 
condensed chromatin undergoes similar changes in structure when macrophage 
nuclei swell in a heterokaryon, making it competent to respond to cytoplasmic 
stimuli which  induce DNA  synthesis. 
Actinomycin prevents initiation of macrophage DNA synthesis most effec- 
tively when treatment of heterokaryons is started 1-4 hr before DNA synthesis. 
Although the nature and function of the RNA species which are involved in 
the initiation of DNA synthesis are completely obscure, higher doses of actino- 336  MACROPHAGE--MELANOCYTE HETEROKARYONS.  II 
mycin are needed to prevent the initiation of DNA synthesis than to inhibit 
the  bulk  of  RNA  synthesis. These  results  are  compatible  with  a  model  in 
which new RNA species,  perhaps  messenger RNA,  made some hours before 
DNA synthesis, determine a  new round of DNA  replication. 
Heterokaryons,  therefore,  conform to  other model systems for stimulated 
I)NA synthesis, in which early changes in RNA synthesis take place and where 
inhibitors of RNA synthesis delay or abolish the entry of cells into S (6,  17). 
There is, however, a striking difference between other models and macrophage- 
illelanocyte heterokaryons in  that the  prereplicative  period  is  reduced from 
the usual 12-15  hr or longer, to 2-3 hr (17, 11). This difference is presumably 
due  to  the  direct  use  of melanocytic products  by the macrophage  nucleus, 
bypassing many steps  essential for DNA synthesis in unfused cells. 
Evidence has been presented that only the melanocyte nucleus provides the 
RNA  species  necessary  for  macrophage  DNA  synthesis  in  heterokaryons. 
Bromotubercidin  pretreatment  of  melanocytes before  fusion  selectively in- 
hibited macrophage DNA  synthesis after fusion, without affecting its RNA 
synthesis.  Other  evidence  also  argues  that  the  stimulation  in  macrophage 
RNA  synthesis is  not  critical  for  subsequent  DNA  synthesis.  1V[acrophage 
I)NA synthesis is most sensitive to actinomycin treatment before macrophage 
RNA synthesis is nmch increased and macrophages which have been treated 
with  high doses of  actinomycin before fusion make DNA,  but  little RNA, 
afterwards. 
The use of inhibitors to achieve selective effects in heterokaryons presents 
some interesting problems. Since the cell fusion process itself is independent of 
DNA,  RNA  or  protein  synthesis,  it  is  possible  to  treat  cells  with various 
inhibitors before, as well as at the time of, fusion (18). An important complica- 
tion  arises  if  the  inhibitor  diffuses from  treated  to  untreated  regions  of  a 
heterokaryon. Actinomycin, which is noncovalently bound to DNA,  readily 
attacks untreated nuclei in heterokaryons (19).  However, bromotubercidin is 
incorporated into RNA and does not give rise to such cross-toxicity. 
Once  the  macrophage  nucleus  becomes  activated  in  the  heterokaryon  it 
becomes less sensitive to the action of actinomycin. Macrophages which make 
no RNA after treatment with 1 ttg/ml actinomycin showed unimpaired stimu- 
lation of RNA  synthesis after fusion with untreated melanocytes. Ringertz 
and his coworkers contend that RNA synthesis and the binding of actinomycin 
D vary in different cells in parallel with the functional state of their chromatin 
(20).  Activation of a  pretreated macrophage nucleus in a  heterokaryon may 
make new sites,  unoccupied by actinomycin, available for RNA synthesis. 
Studies  to  be  reported  in  a  subsequent  colmnunication will  describe  the 
requirements for protein synthesis and the use of synchronized melanocytes 
in the initiation of macrophage DNA synthesis. SAI~0N GORDON AND ZANVIL COHN  337 
SUMMARY 
Mouse peritoneal macrophages, which do not synthesize DNA in vitro, were 
fused with melanocytes, a mouse cell strain which proliferates rapidly in vitro. 
DNA  synthesis  was  induced  in  macrophage  nuclei 2-3  hr  after fusion  and 
occurred irrespective of the number of macrophage nuclei present per melano- 
cyte nucleus  in  each heterokaryon.  50-80%  of macrophage  nuclei  initiated 
DNA synthesis in the 3-7 hr period after fusion. The activation of most 11-12- 
day chick red cell nuclei in melanocyte cytoplasm took longer than 10 hr. The 
lag  before DNA  synthesis may reflect the heterochromafin content of  each 
nucleus. 
Studies  with  actinomycin showed  that  heterokaryon RNA  synthesis  was 
essential  for  subsequent  macrophage  DNA  synthesis.  This  RNA  was  syn- 
thesized 1-4 hr before the DNA and was unlikely to be ribosomal RNA,  since 
it was insensitive to <0.1 #g/ml actinomycin. 
Melanocytes and macrophages were treated before fusion with actinomycin 
and bromotubercidin to bring about a more selective inhibition of RNA syn- 
thesis. Macrophages pretreated for 1 hr with 5/zg/ml of actinomycin showed 
less than 20%  of control RNA synthesis in the first 4  hr after fusion, but a 
normal activation of macrophage I)NA synthesis. Pretreatment of melanocytes 
for 3-7 hr with 5 #g/ml bromotubercidin, a reversible inhibitor of RNA syn- 
thesis,  prevented macrophage DNA  synthesis without  affecting macrophage 
RNA synthesis in the heterokaryons (81% of control). These studies showed 
that  only  melanocyte  RNA  synthesis  was  essential  for  the  production  of 
macrophage DNA. 
The exposure of one cell partner to actinomycin before fusion caused cross- 
toxicity of the untreated nucleus after fusion. Bromotubercidin, an adenosine 
analogue which  is  incorporated into  RNA,  did  not  give rise  to  such  cross- 
toxicity after fusion. 
Once  the  macrophage  nucleus  becomes  activated  in  the  heterokaryon it 
becomes less sensitive to the action of actinomycin. 
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